Toronto/Winnipeg — Canadian medical marijuana is setting the stage to go global. The country’s emerging legal producers have a chance to seize opportunities in other countries that could make them worldwide leaders, according to Canopy Growth Corporation CEO Bruce Linton. "If you pick a theme for 2018 it will be the globalisation of medical cannabis," said Linton, whose company is the world’s largest publicly traded medical marijuana producer. "It’s not difficult to see a really substantial global market coming off what starts here." Linton’s comments come at the end of dynamic year for Canopy and its peers. There are now at least 80 cannabis companies listed on Canadian exchanges whose combined market value has ballooned to more than C$20bn ($15.9bn), according to data compiled by Bloomberg. Canopy and four other growers — Aurora Cannabis, Aphria, MedReleaf and Cronos Group — are valued at more than C$1bn. More are coming: 208 companies that have applied to be licensed producers ar...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.